The National Action Plan on Antimicrobial resistance in Vietnam Period from 2013 to 2020

Similar documents
2016/LSIF/FOR/003 Strengthening Surveillance and Laboratory Capacity to Fight Healthcare Associated Infections Antimicrobial Resistance

Regional Workshop on AMR in South East Asia Penang (Malaysia): March 2018

Implementation of a National Action Plan and International standards especially with regard to Responsible and prudent use of antimicrobials

The South African Antimicrobial Resistance Strategy Framework

VIETNAM: Progress report Survey on AMU and AMR in aquaculture

VIETNAM S RESIDUE CONTROL PLAN FOR EXPORTING HONEY IN PRODUCTION, COLLECTION AND PROCESSING

Strengthening capacity for the implementation of One Health in Viet Nam, Phase 2 (SCOH2) TERMS OF REFERENCE

Reducing antibiotic use in food animals: Status, challenges and initiatives in Vietnam

Action and Experience of Containment of AMR in Veterinary Sector JAPAN

Perspective on AnA Global timicrobial Resistance

National Surveillance of Antimicrobial Resistance

Antimicrobial Stewardship: The South African Perspective

Antimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr. Nils Anders Tegnell, Director, The

NATIONAL ACTION PLAN ON COMBATTING DRUG RESISTANCE in the period from

The South African AMR strategy. 3 rd Annual Regulatory Workshop Gavin Steel Sector wide Procurement National Department of Health; South Africa

COUNTRY REPORT THAILAND. Sasi Jaroenpoj Department of Livestock Development

Ecohealth Approach to Develop a Strategy for the Prudent Use of Antimicrobials to Control Antimicrobial Resistance in Human, Animal, and

NAP on AMR: Singapore

REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT

International Food Safety Authorities Network (INFOSAN) Antimicrobial Resistance from Food Animals

National Action Plan development support tools

Antimicrobial Resistance, yes we care! The European Joint Action

The UK strategy for antimicrobial resistance (AMR) and its implications for research and development

OECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH. Michele Cecchini OECD Health Division

ANTIMICROBIAL RESISTANCE

Jaipur Declaration on Antimicrobial Resistance

IFMSA Policy Proposal Antimicrobial Resistance

Dr Liz Tayler Antimicrobial Resistance Secretariat Global action plan on antimicrobial resistance

The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England

OIE AMR Strategy, One Health concept and Tripartite activities

China Training Seminar on the OIE PVS Tool for East Asia Seoul, Republic of Korea, April 2016

Dr Marc Sprenger Director Antimicrobial Resistance Secretariat Global action plan on antimicrobial resistance

India: Policies and perspectives on Antimicrobial Resistance

Antimicrobial Use and Antimicrobial Resistance in Relation to the Canadian Pork Sector Presented by Jorge Correa Pork Committee Banff May 2013

Action Plan Goal 2 Surveillance and Monitoring Strategies:

GHSA Prevent-1 (AMR) road map: Progress and implementation plan Dr. Anders Tegnell, Ministry of Health and Social Affairs, Sweden

ANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU

Dr Nata Menabde Executive Director World Health Organization Office at the United Nations Global action plan on antimicrobial resistance

Antimicrobial Resistance at human-animal interface in the Asia-Pacific Region

Veterinary antimicrobials: state of play and future developments 2013 European Medicines Agency/IFAH- Europe Info Day 7-8 March 2013

Dr Elisabeth Erlacher Vindel Head of Science and New Technologies Departement OIE AMR strategy and activities related to animal health

Antimicrobial resistance at different levels of health-care services in Nepal

ANTIMICROBIAL RESISTANCE: GLOBAL BURDEN

The Permanent Secretary, Ministry of Public Health and Sanitation. The Permanent Secretary, Ministry of Livestock Development

Resolution adopted by the General Assembly on 5 October [without reference to a Main Committee (A/71/L.2)]

EU strategy to fight against Antimicrobial Resistance

Activities for Zoonotic Diseases in Cambodia

Surveillance of AMR in PHE: a multidisciplinary,

Strengthening of Veterinary Services in Developing Countries + Rabies Control

14th Conference of the OIE Regional Commission for Africa. Arusha (Tanzania), January 2001

Antimicrobial resistance (AMR)

FAO-OIE-WHO Tripartite Positions and Actions on Antimicrobial Resistance (AMR)

Antibiotic resistance is one of the biggest threats to global health, food security, and development today.

WHO perspective on antimicrobial resistance

OIE Strategy on Antimicrobial Resistance and the need for new diagnostic tools

YOU YOU WE NEED. To implement the new Antimicrobial Resistance campaign TO HANDLE ANTIMICR BIALS WITH CARE. October Veterinary Services

DR. BASHIRU BOI KIKIMOTO

First-year experiences in implementing Thailand s National Strategic Plan on AMR

RECENT ACTIVITIES OF THE NATIONAL FOCAL POINT FOR VETERINARY PRODUCTS - SWAZILAND PRESENTATION TO

Hosted by Dr. Benedetta Allegranzi, WHO Patient Safety Agency A Webber Training Teleclass

What Canadian vets need to know and explain about antimicrobial resistance

Escalating Problem on Pseudomonas and Acinobacter Resistance and MDRO

Actions for combatting Antimicrobial Resistance (AMR)

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE

Would you like to be added to our mailing list to receive updates on the development of the global action plan?* Y X N

WORLD ANTIBIOTIC AWARENESS WEEK

SECOND REPORT FROM THE COMMISSION TO THE COUNCIL

Building Competence and Confidence. The OIE PVS Pathway

Global Action Plan on AMR and Follow up

COUNTRY PRESENTATION ON RECENT ACTIVITIES CARRIED OUT BY FOCAL POINT BHUTAN

Evaluation of Performance of Veterinary Services - Viet Nam experience

Korea s experience of total ban of antibiotics in animal feed

Stratégie et action européennes

Promoting One Health : the international perspective OIE

WELSH HEALTH CIRCULAR

German Antimicrobial Resistance Strategy DART 2020

OIE Standards for: Animal identification and traceability Antimicrobials

Global Action Plan on Antimicrobial Resistance

The European AMR Challenge - strategic views from the human perspective -

Responsible Use of Antibiotics Saves Lives. 54 th National Pharmacy Week (NPW) th to 21 st November, 2015 Indian Pharmaceutical Association

TEXTS ADOPTED Provisional edition. P8_TA-PROV(2018)0429 Animal welfare, antimicrobial use and the environmental impact of industrial broiler farming

ZOONOSIS SURVEILLANCE SYSTEMS IN COTE D IVOIRE IN THE CONCEPT OF ONE HEALTH : STRENGTHS, CHALLENGES AND PERPECTIVES

Rabies Control in China

Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune

Dr. Gérard Moulin AFSSA/ANMV OIE Collaborating Centre on Veterinary medicinal products BP FOUGERES CEDEX, FRANCE

EXPERIENCE ON ANTIMICROBIAL USE AND RESISTANCE IN KENYA

One Health Collaboration to combat Antimicrobial resistance

RUMA: Advocating Prudent Use of Antimicrobial Compounds

2016/LSIF/FOR/004 Policies to Promote Patient Access to Innovative Treatments and Combat Antimicrobial Resistance

The Commission activities on AMR (focus on zoonotic issues)

Global Strategies to Address AMR Carmem Lúcia Pessoa-Silva, MD, PhD Antimicrobial Resistance Secretariat

GARP ACTIVITIES IN KENYA. Sam Kariuki and Cara Winters

Pfizer Position on Antimicrobial Resistance Management. Kirill Tverskoy, Medical Director Pfizer Russia February 21, 2017

WHO s first global report on antibiotic resistance reveals serious, worldwide threat to public health

OIE Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials in Animals Part I

OIE Regional Commission for Europe Regional Work Plan Framework Version adopted during the 85 th OIE General Session (Paris, May 2017)

The APUA Global Chapter Network:

Government Initiatives to Combat Antimicrobial Resistance (AMR)

Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics

CHALLENGES AND COLLABORATION

Transcription:

The National Action Plan on Antimicrobial resistance in Vietnam Period from 2013 to 2020 Ha Ngo Thi Bich Medical Service Administration Ministry of Health of Vietnam

MINISTER OF HEALTH DEPUTY MINISTER NGUYỄN THỊ XUYÊN DEPUTY MINISTER LÊ QUANG CƯỜNG DEPUTY MINISTER PHẠM LÊ TUẤN DEPUTY MINISTER NGUYỄN THANH LONG DEPUTY MINISTER NGUYỄN VIẾT TIẾN CABINET MEDICAL SERVICE MOTHER & CHILD HEALTH TRADITIONAL MEDICINE PREVENTIVE MEDICINE HIV/AIDS CONTROL SCIENCE, TECHNOLOGY & EDUCATION DRUG MANAGEMENT HEALTH EDUCATION HEALTH ENVIROMENT HEALTH INSPECTION HEALTH LEGISLATION POPULATION & FAMILY PLANNING INTERNATIONAL COOPERATION HEALTH INSURANCE INFORMATION TECNOLOGY PLANING & FINANCING ORGANIZATION & HUMAN RESOURCE

Public Hospital Network MINISTRY OF HEALTH Tertiary 42 MoH's hospitals 27.255 beds 11,6 % total beds 63 PROVINCIAL DEPARTMENT Secondary 420 Provincial Hospitals 117.116 beds 49.7% 641 DISTRICT HEALTH BUREAU First Medical Referral 614 Dítrict Hospitals 71.711 beds 30,4% 11.000 COMMUNITIES Primary care 11.000 Commune Health Centre

Introdution The extent and rate of drug resistance are increasing. The burden of drug resistance: increased cost of treatment, days of hospitalization last, high morbidity and mortality, ect. The problem of drug resistance is becoming more emergency and requires the efforts of society to prevent this situation. Responding to the call of the World Health Organization: no action today, no cure tomorrow National Action Plan on antimicrobial resistance period from 2013 to 2020 have issued (Decision No. 2174/QD-BYT June 21, 2013).

The National Action Plan on AMR Part one: RATIONAL Background Practical basis The legal basis Part two: THE CONTENT OF THE PLAN Goal Activities Part Three: SOLUTIONS Part four: IMPLEMENTATION

The reality In the community, the majority of antibiotics are sold without a prescription: urban (88%) and rural (91%). Infection of bacterial resistance often fail to conventional therapy, prolonged treatment, increasing the cost and risk of death. In cultivation and livestock antibiotics are used to stimulate the growth or prevention and treatment of disease, if that is not controlled it would cause great risk to the environment and human health due to drug resistance.

Treatment by antibiotic 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% KS không thích hợp KS thích hợp 84% 74% 67% 33% 26% 16% Tổng cộng E.coli hay Klebsiella Acinetobacter hay Pseudomonas Unappropriate use of antibiotic is 74% and appropriate one is 26% (similar to results of Kollef et al. in 1998 (73.3%)) MSA s research in 2009-2010 at 19 hospitals in HN, HCM, HP

Bacteria s resistance Figure 2. Resistance rates for four common Gram-negative bacteria isolated from routine clinical sample (sputum, urine, blood, pus) in hospitalized patients, MoH, 2008-09.

Type of hospital infection & common isolated bacteria Hospital infection: pneumonia by machine or not, septicaemia Negative gram bacteria, include Acinetobacter spp, Klebsiella pneumonia, Pseudomonas aeruginosa, E. coli

Goal Promote activities to prevent drug resistance, contribute to improving the quality and effectiveness of the prevention and control of epidemics, treatment to protect, care and improve people's health. Activities Raising awareness of the community and health workers on drug resistance Enhance, improve capacity of the national surveillance system for antibiotic use and antimicrobial resistance Ensuring adequate supply of quality essential drugs Improve safe and rational use of medicine Strengthen infection control Part two: CONTENT Strengthen safe, appropriate antibiotic use in livestock, poultry, aquaculture and cultivation.

Part three: SOLUTIONS 1. Policy, mechanism and management 2. Information, communication and education 3. Technical expertise and training 4. Finance 5. Scientific research and international cooperation

Challenges Workforce development limited Awareness of population, health workers, policy makers Cooperation mechanism between MoH and MoARD Capacity of microbiological laboratories remains weak in both quantity and quality. The quality of medicine is not been controlled closely Poor infection control practices Misuse, overuse of antibiotic and treatment of diseases caused by not bacteria, lack of data on resistant bacteria Buy antibiotic without physician s prescription

Solutions Set up the National Steering Committee on AMR including MoH and MoARD. Set up subcommittee for surveillance AMR in community and health facilities Guideline on antibiotic use issued Guideline for Antimicrobial Stewardship Program in hospital developing. Survey of the reality of human resource, qualifications, equipments of all microbiological departments in the whole country. Developing a Circular regulating functions and duties for microbiological laboratory in hospital is

Solutions Implementing communication plans to raise awareness of the population and health workers about AMR (radio, TV spot, news, meeting, to parade the streets) Strengthening activities of infection control in hospitals Establishment a national surveillance network on AMR Closely co-ordination between treatment system and preventive medical one Enhancing technical assistance and financing of the development partners such as WHO, FAO, OIE, UK, CDC.US, Sweden, ect.

Antibiotics are a precious resource We need to preserve this resource by working together

Thank you for your attention!